DRW Holdings »

Apellis Pharmaceuticals shares owned by DRW Holdings

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by DRW Holdings from 13F filings

Historical chart of DRW Holdings investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by DRW Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by DRW Holdings

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.4M 34k 40.23

More positions owned by DRW Holdings

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
iShares Russell 2000 Index Call Option (IWM)
NVIDIA Corporation Call Option (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Alphabet Inc Class A cs Call Option (GOOGL)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Tesla Motors Call Option (TSLA)
Asml Holding N V N Y Registry Shs Call Option (ASML)
Astrazeneca Plc Each Ads Representing 1/2 Of An Or Ordinary Share Call Option (AZN)
Advanced Micro Devices Call Option (AMD)
Ishares Core Msci Emkt (IEMG)
Facebook Inc cl a Call Option (META)
Vestas Put Option (VWSYF)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr China Lg-cap Etf (FXI)

View all positions for DRW Holdings

Top funds holding Apellis Pharmaceuticals

BlackRock
Wellington Management Company
venBio Select Advisor
Vanguard Group
Morgan Stanley
Rtw Investments
UBS Group
Vanguard Portfolio Management
Pentwater Capital Management
Vanguard Capital Management
State Street Corporation
Deep Track Capital
Point72 Asset Management
Polar Capital Holdings
HBK Investments

View all funds holding Apellis Pharmaceuticals